News | May 05, 2026
SK Capital sells Noramco assets to Siegfried
Keeps Halo Pharma to drive independent growth
Keeps Halo Pharma to drive independent growth
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
New medical and wellness centre combines on-site care with telehealth to support industrial workforce and surrounding communities
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
The company allocated €56 million to research and development for next-generation line solutions
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
The patent, titled “ALPHA-1062 for treating Traumatic Brain Injury,” strengthens Alpha Cognition’s existing portfolio supporting both ALPHA-1062 and ZUNVEYL
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The approval comes after a systematic review of published literature
Subscribe To Our Newsletter & Stay Updated
